SCHEMBL7341990

SCHEMBL7341990

CN1CCN(CC(=O)N(Cc2ccccc2)c2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
KDM4E B2RXH2 3/20 0.57
TSHR P16473 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
GLA P06280 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54
PAX8 Q06710 1/20 0.54
LTB4R2 Q9NPC1 1/20 0.52
OPRM1 P35372 3/20 0.51
SIGMAR1 Q99720 3/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
POLB P06746 1/20 0.50
HDAC1 Q13547 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
DRD4 P21917 1/20 0.48
MC4R P32245 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7342306 0.92 MEN1 (0.56) ALDH1A1KDM4ETSHRSMN1; SMN2NPC1
SCHEMBL7340688 0.92 ALDH1A1 (0.55) ALDH1A1KDM4ETSHRSMN1; SMN2NPC1
SCHEMBL7349167 0.89 RNF4 (0.59) ALDH1A1KDM4ETSHROPRM1KMT2A
SCHEMBL7342383 0.85 HDAC1 (0.69) ALDH1A1KDM4ETSHRSMN1; SMN2LTB4R2
SCHEMBL7339635 0.84 ALDH1A1 (0.54) ALDH1A1KDM4ETSHRSMN1; SMN2NPC1
SCHEMBL7339476 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ETSHRSMN1; SMN2NPC1
SCHEMBL7339492 0.82 POLB (0.58) ALDH1A1KDM4ETSHRSMN1; SMN2OPRM1
SCHEMBL7349543 0.82 ALDH1A1 (0.55) ALDH1A1KDM4ETSHRSMN1; SMN2NPC1
SCHEMBL7347840 0.82 MAPT (0.50) ALDH1A1KDM4ETSHROPRM1KMT2A
SCHEMBL14174757 0.81 MEN1 (0.61) ALDH1A1KDM4ETSHRSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0585500-A1 Diaryl piperazineacetamides as antimuscarinic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1994-03-09 EP disclosed